Literature DB >> 1466764

Chemical modification of interleukin-1 beta: biochemical characterization of a carbodiimide-catalyzed intramolecular cross-linked protein.

A W Yem1, D M Guido, W R Mathews, N D Staite, K A Richard, M D Prairie, W C Krueger, D E Epps, M R Deibel.   

Abstract

We have modified recombinant human Interleukin-1 beta using 1-ethyl-3(3-dimethylaminopropyl)-carbodiimide at pH 6.5, resulting in the formation of an internally cross-linked protein. The major product (30% yield) of the reaction (17 kD; pI = 6.2) was purified and fully characterized by peptide mapping using Endoproteinase Lys C. When digests were conducted under nondenaturing conditions, we found that the modified protein is different from the native protein. The native protein yielded 14 peptides after digestion, whereas only two large peptides and a tetrapeptide, Asn-Tyr-Pro-Lys, were released from the cross-linked protein (i.e., cleavage occurs only at residues Lys88 and Lys92). Using gel filtration, the two peptides were found to co-elute as a single species (15 kD), which represent a noncovalent complex of the amino terminal and C-terminal portions of the molecule. Further analysis of the modified protein by peptide mapping under denaturing conditions and by FAB MS analysis showed that Glu111 and Lys138 were internally cross-linked. The cross-linked protein had bioactivity (T-cell proliferation), fluorescence, and circular dichroism spectra similar to native IL-1 beta. In contrast, while having similar secondary structure, the digested cross-linked protein had less than 1% of T-cell proliferative activity of the undigested protein. These data show that the structural integrity surrounding and perhaps including the Asn-Tyr-Pro-Lys region may be crucial for the biological activity of rIL-1 beta and may be important for the binding of IL-1 to its receptor.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1466764     DOI: 10.1007/bf01024972

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  31 in total

1.  Characterization of lymphocyte-activating factor (LAF) produced by the macrophage cell line, P388D1. I. Enhancement of LAF production by activated T lymphocytes.

Authors:  S B Mizel; J J Oppenheim; D L Rosenstreich
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

2.  Effects of lectins and tunicamycin on IL-1 binding to YT cells.

Authors:  S C Speziale; L C Ginsberg; J W Paslay
Journal:  Lymphokine Res       Date:  1989

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Conformation, stability, and folding of interleukin 1 beta.

Authors:  S Craig; U Schmeissner; P Wingfield; R H Pain
Journal:  Biochemistry       Date:  1987-06-16       Impact factor: 3.162

5.  A procedure to increase the sensitivity of staining by Coomassie brilliant blue G250-perchloric acid solution.

Authors:  I B Holbrook; A G Leaver
Journal:  Anal Biochem       Date:  1976-10       Impact factor: 3.365

6.  Crystal structure of recombinant human interleukin-1 beta at 2.0 A resolution.

Authors:  B C Finzel; L L Clancy; D R Holland; S W Muchmore; K D Watenpaugh; H M Einspahr
Journal:  J Mol Biol       Date:  1989-10-20       Impact factor: 5.469

7.  Resolution and biological properties of three N-terminal analogues of recombinant human interleukin-1 beta.

Authors:  A W Yem; K A Richard; N D Staite; M R Deibel
Journal:  Lymphokine Res       Date:  1988

8.  Complete amino acid sequence and predicted membrane topology of phenobarbital-induced cytochrome P-450 (isozyme 2) from rabbit liver microsomes.

Authors:  G E Tarr; S D Black; V S Fujita; M J Coon
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

9.  Muteins of human interleukin-1 that show enhanced bioactivities.

Authors:  J J Huang; R C Newton; R Horuk; J B Matthew; M Covington; K Pezzella; Y A Lin
Journal:  FEBS Lett       Date:  1987-11-02       Impact factor: 4.124

10.  Crystal structure of the cytokine interleukin-1 beta.

Authors:  J P Priestle; H P Schär; M G Grütter
Journal:  EMBO J       Date:  1988-02       Impact factor: 11.598

View more
  1 in total

1.  Arg-27, Arg-127 and Arg-155 in the beta-trefoil protein barley alpha-amylase/subtilisin inhibitor are interface residues in the complex with barley alpha-amylase 2.

Authors:  K W Rodenburg; E Várallyay; I Svendsen; B Svensson
Journal:  Biochem J       Date:  1995-08-01       Impact factor: 3.857

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.